| Matt L Loewen, DO | |
|
1600 N Westgate Dr Ste 800, Weslaco, TX 78596-4952 | |
| (956) 854-4260 | |
| (956) 854-4266 |
| Full Name | Matt L Loewen |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 42 Years |
| Location | 1600 N Westgate Dr Ste 800, Weslaco, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720072358 | NPI | - | NPPES |
| 133831110 | Medicaid | TX | |
| 0A6188 | Other | TX | MEDICARE- GROUP |
| 8F24345 | Other | TX | MEDICARE - INDIVIDUAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | G3026 (Texas) | Primary |
| 207Q00000X | Family Medicine | 2290 (Oklahoma) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Current Care Pa | 9739260019 | 429 |
News Archive
A new study from The Ohio State University College of Nursing quantifies how the COVID-19 pandemic, coupled with variable workplace wellness cultures and long shifts caring for patients, has severely impacted nurses working on the front lines.
High-risk human papillomavirus is an etiologic factor in approximately 6% of cases of oral cavity squamous cell carcinoma, according to epidemiologic research.
Intrinsic Therapeutics, Inc., a developer of novel lumbar spine anulus closure devices, announced today that it has enrolled the first patient, December 17, 2010, in a Randomized Clinical Trial of its Barricaid device.
A team of researchers led by Elliott Dasenbrook, MD, MHS, Assistant Professor of Medicine and Pediatrics at Case Western Reserve University School of Medicine and Associate Director of the Adult Cystic Fibrosis Program at University Hospitals Case Medical Center's Rainbow Babies & Children's Hospital today published the findings from a major study about cystic fibrosis survival rates in the June 16 issue of JAMA.
› Verified 2 days ago
| Entity Name | American Current Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275651002 PECOS PAC ID: 9739260019 Enrollment ID: O20080131000349 |
News Archive
A new study from The Ohio State University College of Nursing quantifies how the COVID-19 pandemic, coupled with variable workplace wellness cultures and long shifts caring for patients, has severely impacted nurses working on the front lines.
High-risk human papillomavirus is an etiologic factor in approximately 6% of cases of oral cavity squamous cell carcinoma, according to epidemiologic research.
Intrinsic Therapeutics, Inc., a developer of novel lumbar spine anulus closure devices, announced today that it has enrolled the first patient, December 17, 2010, in a Randomized Clinical Trial of its Barricaid device.
A team of researchers led by Elliott Dasenbrook, MD, MHS, Assistant Professor of Medicine and Pediatrics at Case Western Reserve University School of Medicine and Associate Director of the Adult Cystic Fibrosis Program at University Hospitals Case Medical Center's Rainbow Babies & Children's Hospital today published the findings from a major study about cystic fibrosis survival rates in the June 16 issue of JAMA.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matt L Loewen, DO 1401 E 8th St, Weslaco, TX 78596-6640 Ph: (956) 854-4260 | Matt L Loewen, DO 1600 N Westgate Dr Ste 800, Weslaco, TX 78596-4952 Ph: (956) 854-4260 |
News Archive
A new study from The Ohio State University College of Nursing quantifies how the COVID-19 pandemic, coupled with variable workplace wellness cultures and long shifts caring for patients, has severely impacted nurses working on the front lines.
High-risk human papillomavirus is an etiologic factor in approximately 6% of cases of oral cavity squamous cell carcinoma, according to epidemiologic research.
Intrinsic Therapeutics, Inc., a developer of novel lumbar spine anulus closure devices, announced today that it has enrolled the first patient, December 17, 2010, in a Randomized Clinical Trial of its Barricaid device.
A team of researchers led by Elliott Dasenbrook, MD, MHS, Assistant Professor of Medicine and Pediatrics at Case Western Reserve University School of Medicine and Associate Director of the Adult Cystic Fibrosis Program at University Hospitals Case Medical Center's Rainbow Babies & Children's Hospital today published the findings from a major study about cystic fibrosis survival rates in the June 16 issue of JAMA.
› Verified 2 days ago
Dr. Armando I Gutierrez, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 James St, Weslaco, TX 78596 Phone: 956-647-8600 Fax: 956-969-9564 | |
Melecia Fuentes, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1206 E 6th St, Weslaco, TX 78596 Phone: 956-447-8377 Fax: 956-973-8034 | |
Renee Terene Gounden, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 555 S International Blvd Ste B-100, Weslaco, TX 78596 Phone: 956-477-1515 | |
Benjamin A Salinas, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1609 N International Blvd, Weslaco, TX 78599 Phone: 956-565-2727 Fax: 956-351-5786 | |
Jorge Saenz, MD PA Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1416 E Expressway 83, Ste. 2, Weslaco, TX 78596 Phone: 956-546-1497 | |
Larissa Nyvia Riojas, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1206 E 6th St, Weslaco, TX 78596 Phone: 956-447-8377 Fax: 956-973-8034 | |
Dr. Michael Eisen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1315 E 6th St Ste 10, Weslaco, TX 78596 Phone: 956-296-2821 Fax: 956-447-9696 |